NVLX News 5-3-2011:
Nuvilex, Inc. Announces Opening of Operations Facility
46 minutes ago - BIZ via Comtex
BusinessWire
Nuvilex, Inc. (OTCQB: NVLX) is pleased to announce the opening of an operations facility, with an initial focus on Cinnergen. This development enables Nuvilex to centralize the Division's operations and consolidates control of manufacturing, fulfillment, marketing and distribution.
Nuvilex's President and Chief Executive Officer, Dr. Robert Ryan, commented, "As a result of the growth we have seen and the increased complexity of management, we centralized operations to be structured for anticipated growth. In addition, experienced management will oversee day-to-day operations and provide input for future needs. Mr. Frank Ross is now Head of the Operations Facility located in Mesa, Ariz. He brings many years of experience to Nuvilex, including experience as a General Manager of multiple multimillion dollar OEM production facilities, and that of a successful private business owner since his early training. I look forward to working with him as he applies the substantial knowledge he has and assists in the growth of not just Cinnergen, but all of Nuvilex's products."
Dr. Ryan further stated, "Incorporating management of distribution into this facility with its ample storage and distribution space, Nuvilex will operate with a greater financial and operational efficiency."
We at Nuvilex are...
a Green Company believing in "Good for You, Good for the Environment," expanding our natural product lines and entering into biotechnology (www.nuvilex.com). Current products include Cinnergen(TM) for healthy glucose maintenance; Cinnechol(TM) to maintain healthy lipids and cardiovasculature; Cinnsational(TM) to decrease detrimental alcohol effects; Talsyn(TM) for keloids, erythema, and scar management; NumaDerm(TM) cosmetic products; Citroxin(TM) and Oraphyte(TM) antimicrobial and antinematodal agents; Reme-Flu(TM), Legacy Biotechnologies' flu combating regimen; and Virgin(R) and Infinitink(R), heavy-metal-free tattoo inks.
Safe Harbor Statement
This information may contain forward-looking statements and involve risks and uncertainties. Results, events and performances could vary from those contemplated. These statements involve risks and uncertainties which may cause actual results, expressed or implied, to differ from predicted outcomes. Risks and uncertainties include product demand, market competition, and Nuvilex's ability to meet current or future plans. Investors should study and understand all risks before making an investment decision. Readers are recommended not to place undue reliance on forward-looking statements or information. Nuvilex is not obliged to publicly release revisions to any forward-looking statement, to reflect events or circumstances afterward, or to disclose unanticipated occurrences, except as required under applicable laws.
AI
